Navigation Links
Pergamum to Provide Effective Development of Innovative Dermatology and Wound Healing Companies
Date:9/10/2009

STOCKHOLM, September 10 /PRNewswire/ -- Pergamum AB has announced its formation; Pergamum will commercialize the Karolinska Development dermatology and wound healing interests, and create a broad-based therapeutic company in its focus areas.

The Pergamum product pipeline consists of five development projects, three of which are undergoing clinical trials. Indications covered within the portfolio include improved wound healing and reduced scar formation, healing hard-to-heal-wounds, the prevention of bacterial and fungal infections, atopic dermatitis and infected wounds and burns.

Pergamum CEO Magnus Precht will present Pergamum at the Rodman & Renshaw Annual Global Investment Conference in New York September 9-11, 2009 and will be available for one-on-one meetings with investors and potential partners during the conference.

"Pergamum represents a unique approach to developing new biopharmaceuticals in the dermatology and wound care markets," said Magnus Precht, CEO of Pergamum AB. "The fact that the group is working within related fields means we are able to build capabilities and specialist knowledge tailored to the needs of the group. We will provide individual projects with access to technical skills and key competencies without creating bureaucratic layers. This should translate into improved quality, cost savings and, ultimately, a shorter path to regulatory approval. It also means we have a broader, more attractive offering when meeting with pharma companies to discuss eventual sales or licensing opportunities," added Mr Precht.

Pergamum's current projects include: wound healing (Omnio Healer), atopic dermatitis / anti-inflamatory (BioCis Pharma), atopic dermatitis / anti-infective (DermaGen), anti-adhesion / wound healing (PharmaSurgics), and wound healing for chronic wounds (Lipopeptide). Karolinska Development owns 64% of Pergamum, with the other owners being Ostersjostiftelsen (The Foundation for Baltic and East European Studies) and Midroc New Technology.

Karolinska Development's CEO, Conny Bogentoft, said, "We are extremely pleased with this new initiative. By consolidating all of our interests in the dermatology and wound healing field in this way we have created an extremely resource-efficient business model. It should provide both more effective project development and greater efficiency when seeking exit opportunities."

About Karolinska Development:

Managing one of the largest portfolios of life science research companies in Europe, Karolinska Development

AB is a new type of company focused on filling the innovation gap within the pharmaceutical industry. Using a unique, highly cost-effective model Karolinska Development commercializes internationally renowned life science innovations, helping to deliver the medical products of the future.

    For more information please contact:

    Magnus Precht, CEO, Pergamum AB
    European mobile phone: +46-73-515-7450
    US cell phone:         +1-817-312-7277
    magnus.precht@pergamum.com
   http://www.pergamum.com

    Conny Bogentoft, CEO, Karolinska Development AB
    Cell phone: +46-70-668-61-43
    info@karolinskadevelopment.com
   http://www.karolinskadevelopment.com


'/>"/>
SOURCE Karolinska Development AB
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion
2. Hyland Software Provides Grant Assistance to Kick-Start Technology Projects
3. PDL BioPharma Provides Third Quarter 2009 Revenue Guidance of Approximately $71 Million
4. ValGenesis, Inc., the Leading Provider of Validation Lifecycle Management Solutions to Regulated Life Science Companies, Today Announced Support for EMC Documentum v.6.5
5. ChemBridge Corporation and Collaborative Drug Discovery Announce Strategic Collaboration to Provide Diverse Chemical Libraries Together With Researchers Own Private Data
6. Ambry Genetics Announces Certified Service Provider Status for Agilent Microarrays
7. Leading European Contract Research Organization Selects OmniComm to Provide eClinical Solutions for Important Phase III Study
8. Wyeth Provides Regulatory Update on Prevnar 13* in the United States
9. Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services
10. ThermoGenesis Provides Update on Fiscal 2009 Results
11. GeoVax Labs, Inc. Provides Clinical Studies Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... ... December 09, 2016 , ... DuPont Industrial Biosciences ... the Breakthrough Solution of the Year Award from Platts Global Energy for ... The award was announced at the 18th Platts Global Energy Awards, held in ...
(Date:12/9/2016)... ALBANY, New York , December 9, 2016 /PRNewswire/ ... Research states that the top five players in the  ... of 62.7% in the overall market in 2015. Players ... and Perkin Elmer have remained dominant in the global ... persistent efforts to ensure product innovation. Product upgrades and ...
(Date:12/9/2016)... Dec. 9, 2016 China Cord Blood Corporation (NYSE: ... China,s leading provider of cord blood collection, laboratory ... today announced the results of its 2016 Annual General Meeting, ... S.A.R., China . At ... the re-appointment of KPMG Huazhen LLP as the independent auditors ...
(Date:12/9/2016)... India , December 9, 2016 According ... & Services (Primer, Probe, Custom, Predesigned, Reagent Equipment), Application (Research, PCR, ... Forecasts to 2021" published by MarketsandMarkets, the global market is expected ... in 2016, at a CAGR of 10.6% during the forecast period. ... ...
Breaking Biology Technology:
(Date:12/6/2016)... DALLAS , Dec. 6, 2016 ... criminal justice technology solutions for public safety, investigation, ... (PEP) jointly announced today a five (5) year ... exclusive agreement to expand the rehabilitation and reentry ... PEP History Established in 2004, the Prison ...
(Date:11/30/2016)... , Nov. 30, 2016 Not many of us realize that we ... of recovery so we need to do it well. Inadequate sleep levels have been ... blood pressure, stroke, diabetes, and even cancer. Maybe now is the best ... that could help them to manage their sleep quality? ... ...
(Date:11/29/2016)... Nearly one billion matches per second with DERMALOG,s high-speed AFIS    ... ... DERMALOG is Germany's largest Multi-Biometric supplier: The ... Identification Systems) ... Germany's largest Multi-Biometric supplier: The company's Fingerprint Identification System is part of ...
Breaking Biology News(10 mins):